Skip to content

Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis

Peacock W, Hollander J, Diercks D, Lopatin M, Fonarow G, Emerman C...(+6 more)

Emerg Med J, vol. 25, issue 4 (2008) pp. 205-209

  • 2


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.
  • N/A


    ScienceDirect users who have downloaded this article.
Sign in to save reference


OBJECTIVE: Morphine is a long-standing therapy in acute decompensated heart failure (ADHF), despite few supporting data. A study was undertaken to compare the outcomes of patients who did and did not receive morphine for ADHF. METHODS: The study was a retrospective analysis of the Acute Decompensated Heart Failure National Registry (ADHERE) which enrols hospitalised patients with treatment for, or a primary discharge diagnosis of, ADHF. Patients were stratified into cohorts based on whether or not they received intravenous morphine. ANOVA, Wilcoxon and chi(2) tests were used in univariate analysis, followed by multivariate analysis controlling for parameters previously associated with mortality. Analyses were repeated for ejection fraction subgroups and in patients not on mechanical ventilation. RESULTS: There were 147 362 hospitalisations in ADHERE at December 2004, 20 782 of whom (14.1%) received morphine and 126 580 (85.9%) did not. There were no clinically relevant differences between the groups in the initial age, heart rate, blood pressure, blood urea nitrogen, creatinine, haemoglobin, ejection fraction or atrial fibrillation. A higher prevalence of rest dyspnoea, congestion on chest radiography, rales and raised troponin occurred in the morphine group. Patients on morphine received more inotropes and vasodilators, were more likely to require mechanical ventilation (15.4% vs 2.8%), had a longer median hospitalisation (5.6 vs 4.2 days), more ICU admissions (38.7% vs 14.4%), and had greater mortality (13.0% vs 2.4%) (all p

Author-supplied keywords

  • 0 (Vasodilator Agents)
  • 57-27-2 (Morphine)
  • Acute Disease
  • Aged
  • Aged, 80 and over
  • Cardiopulmonary Resuscitation/statistics & numeric
  • Female
  • Heart Catheterization/statistics & numerical data
  • Heart Failure/*drug therapy
  • Hospital Mortality
  • Hospitalization
  • Humans
  • Intensive Care/statistics & numerical data
  • Length of Stay/statistics & numerical data
  • Male
  • Middle Aged
  • Morphine/adverse effects/*therapeutic use
  • Respiration, Artificial/statistics & numerical dat
  • Retrospective Studies
  • Vasodilator Agents/adverse effects/*therapeutic us

Find this document

Cite this document

Choose a citation style from the tabs below